Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement
Segments

Common Size IS
Op Efficiency
Credit Analysis

InMed Pharmaceuticals Inc. (INM) > Segments

BayMedica

Annual | Quarterly | TTM
  Older >>
In millions, except per share itemsJun-30-23Mar-31-23Sep-30-22Jun-30-22Mar-31-22Dec-31-21Sep-30-21Jun-30-21
   10-K10-Q10-Q10-K10-Q10-Q10-Q10-K
Revenues    1.4     
Gross profit    1.0     
            Gross margin    72.2%     
EBIT    -4.8     
            EBIT margin    -341.3%     
   
Revenue Mix    100.0%     

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy